Patent · US Active

Methods for treatment of Fabry disease

US9480682B2 · kind B2 · utility

48Cited by
10References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 9, 2015
Grant dateNov 1, 2016
Priority date
Expiry dateMar 9, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are in vitro and in vivo methods for determining whether a patient with Fabry disease will respond to treatment with a specific pharmacological chaperone.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.